Abstract:Background. Macrophage-mediated inflammation plays an essential role in the development of atherosclerosis (AS). Long noncoding RNAs (lncRNAs), as crucial regulators, participate in this process. We identified that lnc-MRGPRF-6:1 was significantly upregulated in the plasma exosomes of coronary atherosclerotic disease (CAD) patients in a preliminary work. In the present study, we aim to assess the role of lnc-MRGPRF-6:1 in macrophage-mediated inflammatory process of AS. Methods. The correlation between lnc-MRGPRF-6:1 and inflammatory factors was estimated firstly in plasma exosomes of CAD patients. Subsequently, we established lnc-MRGPRF-6:1 knockout macrophage model via the CRISPR/Cas9 system. We then investigated the regulatory effects of lnc-MRGPRF-6:1 on macrophage polarization and foam cell formation. Eventually, transcriptome analysis by RNA sequencing was carried out to explore the contribution of differential genes and signaling pathways in this process. Results. lnc-MRGPRF-6:1 was highly expressed in the plasma exosomes of CAD patients and was positively correlated with the expression of inflammatory cytokines in plasma. lnc-MRGPRF-6:1 inhibition significantly reduced the formation of foam cells. The expression of lnc-MRGPRF-6:1 was upregulated in M1 macrophage, and lnc-MRGPRF-6:1 knockout decreased the polarization of M1 macrophage. lnc-MRGPRF-6:1 regulates macrophage polarization via the TLR4-MyD88-MAPK signaling pathway. Conclusions. lnc-MRGPRF-6:1 knockdown can inhibit M1 polarization of macrophage and inflammatory response through the TLR4-MyD88-MAPK signaling pathway. lnc-MRGPRF-6:1 is a vital regulator in macrophage-mediated inflammatory process of AS.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the effect of long - chain non - coding RNA (lnc - MRGPRF - 6:1) on macrophage - mediated inflammatory processes in patients with coronary atherosclerotic disease (CAD). Specifically, the researchers aimed to evaluate the role of lnc - MRGPRF - 6:1 in macrophage polarization and inflammatory responses in atherosclerosis (AS), especially how it promotes the polarization of M1 - type macrophages and inflammatory responses through the TLR4 - MyD88 - MAPK signaling pathway. The research background indicates that macrophage - mediated inflammation plays a crucial role in the occurrence and development of atherosclerosis, and long - chain non - coding RNAs (lncRNAs) are involved in this process as important regulatory factors. Preliminary work has found that lnc - MRGPRF - 6:1 is significantly up - regulated in plasma exosomes of CAD patients. Therefore, the goal of this study was to evaluate the role of lnc - MRGPRF - 6:1 in the macrophage - mediated AS inflammatory process. Research methods include: 1. **Correlation analysis**: First, evaluate the correlation between lnc - MRGPRF - 6:1 and inflammatory factors in plasma exosomes of CAD patients. 2. **Gene knockout model establishment**: A macrophage model with lnc - MRGPRF - 6:1 knockout was established through the CRISPR/Cas9 system. 3. **Functional experiments**: Study the influence of lnc - MRGPRF - 6:1 on macrophage polarization and foam cell formation. 4. **Transcriptome analysis**: Explore the contribution of differential genes and signaling pathways in this process through RNA sequencing. Research results show that lnc - MRGPRF - 6:1 is highly expressed in plasma exosomes of CAD patients and is positively correlated with the expression of inflammatory cytokines in plasma. Inhibiting lnc - MRGPRF - 6:1 significantly reduces the formation of foam cells. In addition, lnc - MRGPRF - 6:1 is highly expressed in M1 - type macrophages, and its knockout reduces the polarization of M1 - type macrophages. Further research has found that lnc - MRGPRF - 6:1 regulates macrophage polarization through the TLR4 - MyD88 - MAPK signaling pathway. The conclusion is that knockdown of lnc - MRGPRF - 6:1 can inhibit the polarization and inflammatory response of M1 - type macrophages through the TLR4 - MyD88 - MAPK signaling pathway, thus playing an important role in the macrophage - mediated inflammatory process of AS.

lnc-MRGPRF-6:1 Promotes M1 Polarization of Macrophage and Inflammatory Response through the TLR4-MyD88-MAPK Pathway